Too late, Sanifo drops the development of its messenger RNA vaccine against Covid-19.

Despite positive intermediate results for phase 1-2 of the trial of its messenger RNA vaccine, the French laboratory believes that it would arrive too late on the market, he said on Tuesday.

In fact, 12 billion doses of anti-Covid vaccines will have been produced in total by the end of the year.

Sanofi, on the other hand, continues to develop its other vaccine against the virus, which is currently in the last phase of clinical trials.

  • Laboratory

  • Covid 19

  • epidemic

  • Coronavirus

  • Anti-covid vaccine

  • Vaccination

  • Health

  • Vaccine